Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ERIC +8.4%, UNH +7.4%, CBSH +3.8%, GIL +2.5% (Q1 and FY24 guidance; medium-term financial targets), BK +1.7%, MS +1.2%, MAIN +0.7% (guidance)
Other news:
- MCBC +38.1% (enters into merger agreement with WTFC)
- CGEM +20.7% (announces oversubscribed $280 million private placement - extends cash runway into 2028)
- ITCI +19.7% (announces positive phase 3 topline results from study 501 evaluating lumateperone as adjunctive therapy in patients with major depressive disorder)
- LXEO +5% (FDA has granted Fast Track designation to LX2006)
- PRTA +4.6% (review on Birtamimab mechanism of action)
- ZVRA +2.2% (presents new data)
- PRTC +2.2% (Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100) IP +2% (to acquire DS Smith)
- APLD +1% (secondary stock offering)
Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MITK -5.5%, PNC -0.7%, CFB -0.5%, NTRS -0.5%, JNJ -0.4%